title: GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy.
abstract: BACKGROUND
  Pelizaeus-Merzbacher-like disease (PMLD) is an inherited hypomyelinating leukoencephalopathy with onset in early infancy. Like Pelizaeus-Merzbacher disease (PMD), PMLD is characterized clinically by nystagmus, cerebellar ataxia, and spasticity, due to a permanent lack of myelin deposition in the brain. Mutations in the GJA12 gene, encoding connexin 47 (Cx47), were recently reported in five children with autosomal recessive PMLD.
  
  
  OBJECTIVE
  To evaluate the impact of mutations in the GJA12 gene in, and define the clinical and neuroimaging features of, autosomal recessive PMLD.
  
  
  RESULTS
  The authors screened for GJA12 mutations in 10 additional PMLD families originating from Italy, Pakistan, and Saudi Arabia. Three novel homozygous GJA12 mutations were identified in 12 mutant cases distributed in 3 of 10 families. The mutations segregated with the disease according to an autosomal recessive trait and included one missense (G236S) and two nonsense (L281fs285X and P131fs144X) changes.
  
  
  CONCLUSIONS
  The identification of homozygous mutations predicting the synthesis of aberrant and truncated polypeptides, and their tight segregation with the disease in very large families, clearly demonstrate that the loss of Cx47 function is the cause of the disease. The phenotype of GJA12-related Pelizaeus-Merzbacher-like disease is fairly homogeneous and similar to that of Pelizaeus-Merzbacher disease. However, slower progression of symptoms, greater preservation of cognitive functions, and partial myelination of corticospinal tracts at MRI were distinctive features, which could help in the differential diagnosis.
authors.affiliation: Department of Child Neurology, National Neurological Institute C. Besta, Milano, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Bugiani
authors.forename: S
authors.initials: S
authors.lastname: Al Shahwan
authors.forename: E
authors.initials: E
authors.lastname: Lamantea
authors.forename: A
authors.initials: A
authors.lastname: Bizzi
authors.forename: E
authors.initials: E
authors.lastname: Bakhsh
authors.forename: I
authors.initials: I
authors.lastname: Moroni
authors.forename: M R
authors.initials: MR
authors.lastname: Balestrini
authors.forename: G
authors.initials: G
authors.lastname: Uziel
authors.forename: M
authors.initials: M
authors.lastname: Zeviani
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D015140:Dementia, Vascular / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000453:epidemiology / Q000235:genetics; D020279:Hereditary Central Nervous System Demyelinating Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D006801:Humans; D038622:Internationality; D007558:Italy / Q000453:epidemiology; D008297:Male; D010154:Pakistan / Q000453:epidemiology; D010375:Pedigree; D020371:Pelizaeus-Merzbacher Disease / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D012529:Saudi Arabia / Q000453:epidemiology